Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CASIRIVIMAB\IMDEVIMAB vs CC-4047: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CASIRIVIMAB\IMDEVIMAB vs CC-4047: Safety Overview

Metric	CASIRIVIMAB\IMDEVIMAB	CC-4047
Total FAERS Reports	4,248	114
Deaths Reported	137	65
Death Rate	3.2%	57.0%
Hospitalizations	1,351	49
Average Patient Age	54.3 yrs	67.0 yrs
% Female Patients	55.4%	N/A